Meetings of the Supervisory Board

In the course of the year, the Supervisory Board held eight meetings. The Supervisory Board also met regularly in the absence of the Board of Management. The discussions at the Supervisory Board meetings covered frequently recurring topics, such as safety, reports of its committees, the concluding year of the Advance 2025 strategy, the BRIGHT 2030 strategy, developments in financial results, dividend proposal, financing, business developments, quarterly interim management statements, quarterly press releases, acquisitions and divestments, key investments, annual budget, internal risk management and control systems, succession planning of the Supervisory Board and Board of Management, remuneration for the members of the Board of Management, corporate governance, investor relations, culture and values, the science-based targets, the Financial statements, and the Annual Report. In addition, the Supervisory Board discussed the agenda of the Capital Markets Day, the preparation for the new strategic period, the new ESG reporting regulations, and it approved the share buy-back program in support of the Corbion employee incentive plan.

At the end of September, the Supervisory Board and the Executive Committee held an on-site meeting, which took place in San Francisco (US). At this meeting the progress on the long-term strategy was discussed and the company's new strategy was presented. The Supervisory Board visited Corbion's algae laboratory and received a tour in the pilot plant where they met with the local leadership and staff. The Supervisory Board was provided with specific insight in the algae business. Several external parties were invited to provide their outside-in perspective on the company and the market Corbion operates in. The Supervisory Board also visited two high-tech innovative companies that are working to accelerate innovation and learned about the power of artificial intelligence and robotics in the health and biotechnology field.

Members of the Supervisory Board regularly met with the members of the Executive Committee, business leaders, and members of corporate staff. The external auditor attended the Supervisory Board meeting on 26 February 2025, at which the 2024 Annual Report and Financial statements were recommended for adoption by the Annual General Meeting of Shareholders. As shown in the table below, at all meetings valid quorum was established.

At all Supervisory Board meetings the Board of Management was present. On each occasion, the Supervisory Board took time to discuss certain topics without the presence of the Board of Management.

Before each meeting, the agenda of the Supervisory Board is prepared by the Chair in consultation with the CEO and the Company Secretary. A schedule with recurring topics is maintained and prior to each meeting relevant topics are added to ensure the Supervisory Board is properly informed and updated.

In addition to the regular meetings of the Supervisory Board, the Chair of the Supervisory Board has pre-meetings with the Board of Management and on occasion members of the Supervisory Board would meet with members of the Executive Committee on important affairs or certain specific topics.